178 related articles for article (PubMed ID: 27149525)
21. Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer.
Gyllensten U; Sanner K; Gustavsson I; Lindell M; Wikström I; Wilander E
Br J Cancer; 2011 Aug; 105(5):694-7. PubMed ID: 21811250
[TBL] [Abstract][Full Text] [Related]
22. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
23. Iranian women's psychological responses to positive HPV test result: a qualitative study.
Qaderi K; Mirmolaei ST; Geranmayeh M; Sheikh Hasani S; Farnam F
BMC Womens Health; 2021 Mar; 21(1):128. PubMed ID: 33771159
[TBL] [Abstract][Full Text] [Related]
24. Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program.
Smith LW; Khurshed F; van Niekerk DJ; Krajden M; Greene SB; Hobbs S; Coldman AJ; Franco EL; Ogilvie GS
BMC Public Health; 2014 Oct; 14():1060. PubMed ID: 25303975
[TBL] [Abstract][Full Text] [Related]
25. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
26. Impact of an educational intervention on women's knowledge and acceptability of human papillomavirus self-sampling: a randomized controlled trial in Cameroon.
Sossauer G; Zbinden M; Tebeu PM; Fosso GK; Untiet S; Vassilakos P; Petignat P
PLoS One; 2014; 9(10):e109788. PubMed ID: 25333793
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
[TBL] [Abstract][Full Text] [Related]
28. Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).
Vallely AJB; Saville M; Badman SG; Gabuzzi J; Bolnga J; Mola GDL; Kuk J; Wai M; Munnull G; Garland SM; Brotherton JML; Kelly-Hanku A; Morgan C; Toliman PJ; Kombati Z; Kariwiga G; Babona D; Tan G; Simms KT; Cornall AM; Tabrizi SN; Wand H; Guy R; Canfell K; Kaldor JM
Lancet Glob Health; 2022 Sep; 10(9):e1336-e1346. PubMed ID: 35878625
[TBL] [Abstract][Full Text] [Related]
29. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
[TBL] [Abstract][Full Text] [Related]
30. Type-specific human papillomavirus DNA testing with the genotyping array: a comparison of cervical and vaginal sampling.
Twu NF; Yen MS; Lau HY; Chen YJ; Yu BK; Lin CY
Eur J Obstet Gynecol Reprod Biol; 2011 May; 156(1):96-100. PubMed ID: 21288625
[TBL] [Abstract][Full Text] [Related]
31. Cervical human papillomavirus infection in Mexican women with systemic lupus erythematosus or rheumatoid arthritis.
Rojo-Contreras W; Olivas-Flores EM; Gamez-Nava JI; Montoya-Fuentes H; Trujillo-Hernandez B; Trujillo X; Suarez-Rincon AE; Baltazar-Rodriguez LM; Sanchez-Hernandez J; Ramirez-Flores M; Vazquez-Salcedo J; Rojo-Contreras J; Morales-Romero J; Gonzalez-Lopez L
Lupus; 2012 Apr; 21(4):365-72. PubMed ID: 22020266
[TBL] [Abstract][Full Text] [Related]
32. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
33. Innovation in cervical cancer prevention and control in Mexico.
Lazcano-Ponce E; Allen-Leigh B
Arch Med Res; 2009 Aug; 40(6):486-92. PubMed ID: 19853189
[TBL] [Abstract][Full Text] [Related]
34. Mexican physicians' knowledge and attitudes about the human papillomavirus and cervical cancer: a national survey.
Aldrich T; Becker D; García SG; Lara D
Sex Transm Infect; 2005 Apr; 81(2):135-41. PubMed ID: 15800091
[TBL] [Abstract][Full Text] [Related]
35. ["I felt myself getting sick:" women's perceptions and understandings of a positive human papillomavirus test in Jujuy, Argentina].
Szwarc L; Sánchez Antelo V; Paolino M; Arrossi S
Salud Colect; 2021 Aug; 17():e3572. PubMed ID: 34752024
[TBL] [Abstract][Full Text] [Related]
36. [Counseling for HPV detection when used to screen for cervical cancer: a qualitative study on the needs of women from Michoacan, Mexico].
León-Maldonado L; Allen-Leigh B; Lazcano-Ponce E
Salud Publica Mex; 2014; 56(5):519-27. PubMed ID: 25604297
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial.
Cromwell I; Smith LW; van der Hoek K; Hedden L; Coldman AJ; Cook D; Franco EL; Krajden M; Martin R; Lee MH; Stuart G; van Niekerk D; Ogilvie G; Peacock S
Cancer Med; 2021 May; 10(9):2996-3003. PubMed ID: 33811457
[TBL] [Abstract][Full Text] [Related]
38. Influences on human papillomavirus (HPV)-related information needs among women having HPV tests for follow-up of abnormal cervical cytology.
O'Connor M; Costello L; Murphy J; Prendiville W; Martin CM; O'Leary JJ; Sharp L;
J Fam Plann Reprod Health Care; 2015 Apr; 41(2):134-41. PubMed ID: 25248873
[TBL] [Abstract][Full Text] [Related]
39. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
[TBL] [Abstract][Full Text] [Related]
40. Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study.
Ogilvie GS; Krajden M; van Niekerk DJ; Martin RE; Ehlen TG; Ceballos K; Smith LW; Kan L; Cook DA; Peacock S; Stuart GC; Franco EL; Coldman AJ
Br J Cancer; 2012 Dec; 107(12):1917-24. PubMed ID: 23169286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
